IBDEI1YD ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34648,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,34648,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,34649,0)
 ;;=L40.0^^192^2006^16
 ;;^UTILITY(U,$J,358.3,34649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34649,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,34649,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,34649,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,34650,0)
 ;;=L40.9^^192^2006^17
 ;;^UTILITY(U,$J,358.3,34650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34650,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,34650,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,34650,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,34651,0)
 ;;=L40.3^^192^2006^19
 ;;^UTILITY(U,$J,358.3,34651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34651,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,34651,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,34651,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,34652,0)
 ;;=R21.^^192^2006^20
 ;;^UTILITY(U,$J,358.3,34652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34652,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,34652,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,34652,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,34653,0)
 ;;=L25.9^^192^2006^6
 ;;^UTILITY(U,$J,358.3,34653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34653,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,34653,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,34653,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,34654,0)
 ;;=M34.89^^192^2007^22
 ;;^UTILITY(U,$J,358.3,34654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34654,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,34654,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,34654,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,34655,0)
 ;;=M34.0^^192^2007^20
 ;;^UTILITY(U,$J,358.3,34655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34655,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,34655,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,34655,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,34656,0)
 ;;=F03.90^^192^2007^14
 ;;^UTILITY(U,$J,358.3,34656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34656,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,34656,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,34656,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,34657,0)
 ;;=F06.8^^192^2007^17
 ;;^UTILITY(U,$J,358.3,34657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34657,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,34657,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,34657,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,34658,0)
 ;;=F06.1^^192^2007^1
 ;;^UTILITY(U,$J,358.3,34658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34658,1,3,0)
 ;;=3^Catatonic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,34658,1,4,0)
 ;;=4^F06.1
 ;;^UTILITY(U,$J,358.3,34658,2)
 ;;=^5003054
 ;;^UTILITY(U,$J,358.3,34659,0)
 ;;=G35.^^192^2007^18
 ;;^UTILITY(U,$J,358.3,34659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34659,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,34659,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,34659,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,34660,0)
 ;;=G60.9^^192^2007^15
 ;;^UTILITY(U,$J,358.3,34660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34660,1,3,0)
 ;;=3^Hereditary/Idiopathic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,34660,1,4,0)
 ;;=4^G60.9
 ;;^UTILITY(U,$J,358.3,34660,2)
 ;;=^5004071
 ;;^UTILITY(U,$J,358.3,34661,0)
 ;;=G62.9^^192^2007^19
 ;;^UTILITY(U,$J,358.3,34661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34661,1,3,0)
 ;;=3^Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,34661,1,4,0)
 ;;=4^G62.9
